April 24th 2025
Patients in Australia with chronic health conditions evaluated the effects on their quality of life, changes in pain, and more after 12 months of medical cannabis.
German Medical Cannabis Market Has Yet to Reach Its Full Potential
Published: December 25th 2024 | Updated: March 11th 2025Germany’s Cannabis Act (CanG) is beginning to transform the country's medical cannabis market, with potential opportunities to expand telemedicine, improve physician training, and enhancing accessibility in this rapidly growing industry.
One Case Study Shows How a Woman in the UK Reduced her Prescription Pain Medication With Cannabis
March 30th 2023A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.